Pivotal Group Acquires Precision Science To Build Animal Health Platform

Pivotal Group has acquired Precision Science, a Phoenix-based contract manufacturer of animal health pharmaceuticals, medicated feed additives, and supplements.

The transaction represents Pivotal Group’s first acquisition in animal health. The investment firm plans to use Precision Science as the foundation for a broader platform focused initially on animal health supplements and pharmaceuticals.

Founded in 1989, Precision Science provides contract manufacturing and product research and development for global animal health companies, supplement brands, and entrepreneurs.

New Facility Will Expand Manufacturing Capacity

Pivotal has invested additional capital and operating resources in Precision Science since completing the acquisition.

A major part of the expansion is a highly automated, 130,000-square-foot manufacturing facility under construction in North Phoenix. The building was approximately two-thirds complete at the time of the announcement.

The facility will add three manufacturing lines and enable Precision Science to expand into liquid products. It will also increase the company’s analytical, product-development, storage, and logistics capabilities.

Automation is expected to improve production efficiency while giving Precision Science additional capacity to serve customers developing or expanding animal health products.

The new facility and broader investment program are also expected to create manufacturing and management employment opportunities in Phoenix.

Precision Science will continue operating with an emphasis on quality, safety, and regulatory compliance. Its infrastructure includes an FDA-registered facility, an internal laboratory, and established quality systems.

Supporting Growth In Animal Health Manufacturing

Animal health companies frequently use contract manufacturers to develop and produce pharmaceuticals, supplements, and feed additives without building dedicated production facilities for every product.

Contract manufacturers must maintain the equipment, technical expertise, quality controls, and regulatory systems needed to work across multiple product categories. For customers, these relationships can support product development, manufacturing scale, and market expansion.

Pivotal identified Precision Science’s established market position, Phoenix presence, and potential to expand its capabilities as factors supporting the acquisition.

The investment firm intends to provide capital for technology, employees, manufacturing equipment, and product-development functions. Precision Science will use those resources to respond to customers seeking additional products and production capacity.

CEO Bryan Vincent will continue leading Precision Science. His comments emphasized the expertise of the existing workforce and the need to anticipate where the animal health market is moving.

Pivotal Group is a Phoenix-based private equity investor and company builder founded by Francis Najafi. Its previous investments have included technology companies such as Network Solutions, Global Capacity, Global Meet, and MegaPath. It also owns and operates Promontory, a luxury mountain community in Park City, Utah.

The Precision Science transaction expands Pivotal into a new industry while maintaining its focus on businesses with established operations and long-term growth opportunities.

KEY QUOTES:

The acquisition of Precision Science represents an exciting opportunity for Pivotal Group to build a leading platform focused on animal health starting with supplements and pharmaceuticals. We were particularly attracted to the growing animal health market, and Precision Science’s commitment to quality and innovation. We look forward to supporting the new platform with the capital and resources needed to expand capabilities, invest in people and technology, and build on the strong foundation that Precision Science established over more than three decades.

Francis Najafi, Founder and CEO of Pivotal Group

Our people have built Precision Science by earning our clients’ trust every day, and their expertise and dedication are what will carry us forward. Our clients are asking us to look ahead—to anticipate where animal health is going and invest in the capabilities that will help them get there. Pivotal’s acquisition provides the resources to invest in people, advance product development and build manufacturing capabilities to meet client needs.

Bryan Vincent, CEO of Precision Science